Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07786012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 2026 to Sep 15, 2026
    • Secondary endpoints: details revised at 2 of 6 entries
    • Eligibility criteria expanded, about 4 words
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.
Trial Details
NCT Number NCT07786012
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions
(from sponsor)		 Cesarean Delivery
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov